Evidence map›Paper›PMID 29793764›Full record

ReviewHearing research2018

Animal model studies yield translational solutions for cochlear drug delivery.

R D Frisina, M Budzevich, X Zhu, G V Martinez, J P Walton, D A Borkholder

Open access · greenAbstract readReview
In one paragraph

Review in Hearing research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Sex Differences in the Triad of Acquired Sensorineural Hearing Loss.International journal of molecular sciences · 2021
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

R D FrisinaDept. Chemical & Biomedical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA; Dept. Communication Sciences & Disorders, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA; Dept. Medical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA. Electronic address: rfrisina@usf.edu.
M BudzevichSmall Animal Imaging Lab, Moffitt Cancer Center, Tampa, FL, USA.
X ZhuDept. Chemical & Biomedical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA; Dept. Medical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA.
G V MartinezSmall Animal Imaging Lab, Moffitt Cancer Center, Tampa, FL, USA.
J P WaltonDept. Communication Sciences & Disorders, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA; Dept. Chemical & Biomedical Engineering, Global Center for Hearing & Speech Research, University of South Florida, Tampa, FL, USA.
D A BorkholderMicrosystems Engineering, Rochester Institute of Technology, Rochester, NY, USA.
University of South Florida · USMoffitt Cancer Center · USRochester Institute of Technology · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI Christine O'Connell · 1998 to 2026
$93.5M
Enabling Microsystem Technologies for Advanced Drug DeliveryR01DC014568 · NIDCD · ROCHESTER INSTITUTE OF TECHNOLOGY · PI BORKHOLDER, DAVID A, FRISINA, ROBERT D · 2015 to 2019
$2.7M
NCI NIH HHS P30 CA076292NIDCD NIH HHS R01 DC014568
6 · The paper itself

Abstract

The field of hearing and deafness research is about to enter an era where new cochlear drug delivery methodologies will become more innovative and plentiful. The present report provides a representative review of previous studies where efficacious results have been obtained with animal models, primarily rodents, for protection against acute hearing loss such as acoustic trauma due to noise overexposure, antibiotic use and cancer chemotherapies. These approaches were initiated using systemic injections or oral administrations of otoprotectants. Now, exciting new options for local drug delivery, which opens up the possibilities for utilization of novel otoprotective drugs or compounds that might not be suitable for systemic use, or might interfere with the efficacious actions of chemotherapeutic agents or antibiotics, are being developed. These include interesting use of nanoparticles (with or without magnetic field supplementation), hydrogels, cochlear micropumps, and new transtympanic injectable compounds, sometimes in combination with cochlear implants.

Indexed as

Drug Delivery SystemsAnimalsCochleaHearingHearing LossLabyrinth DiseasesModels, AnimalPharmaceutical PreparationsTranslational Research, BiomedicalPharmaceutical Preparations

Identifiers

PMID29793764
PMCPMC6165691
OpenAlexW2800575259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.